Exact Mass: 394.035705
Exact Mass Matches: 394.035705
Found 151 metabolites which its exact mass value is equals to given mass value 394.035705,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diflufenican
CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5369; ORIGINAL_PRECURSOR_SCAN_NO 5368 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5374; ORIGINAL_PRECURSOR_SCAN_NO 5371 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5368; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5376; ORIGINAL_PRECURSOR_SCAN_NO 5375 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5337; ORIGINAL_PRECURSOR_SCAN_NO 5333 CONFIDENCE standard compound; INTERNAL_ID 4010 CONFIDENCE standard compound; INTERNAL_ID 2315 CONFIDENCE standard compound; INTERNAL_ID 8384
JNJ-7706621
C15H12F2N6O3S (394.06596260000003)
Isorhamnetin 3-sulfate
C16H10O10S (393.99946800000004)
Alilusem
C17H15ClN2O5S (394.03901700000006)
Demethyltorosaflavone C
Kaempferol 7,4-dimethyl ether 3-O-sulfate
C17H14O9S (394.03585140000007)
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
C15H24Br2O2 (394.01429239999993)
methyl 5-chloro-4-O-demethylbarbatate|metyl 5-chloro-4-O-demethylbarbatate
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
Daphnoretine Acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
7-O-acetyldaphnoretin
Origin: Plant, Coumarins
1h,1h,2h,3h,3h-perfluorononane-1,2-diol
C9H7F13O2 (394.02384379999995)
2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE
C18H19ClN2O4S (394.07540040000004)
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
C20H14N2O5S (394.06233940000004)
2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine
Gonyautoxin II
From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.
2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
2-BUTYNYLTRIPHENYLPHOSPHONIUM BROMIDE
C22H20BrP (394.04859100000004)
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
Alilusem
C17H15ClN2O5S (394.03901700000006)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-(2,4-dichlorophenoxy)-N-[4-(morpholin-4-ylmethyl)phenyl]acetamide
C19H20Cl2N2O3 (394.08509100000003)
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
C16H10O10S-2 (393.99946800000004)
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
C16H15BrN2O3S (393.99867000000006)
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
C20H14N2O5S (394.06233940000004)
4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
C19H14N4O4S (394.07357240000005)
4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide
Uracil octosyl acid 5-phosphate
C12H15N2O11P (394.04134500000004)
An N-glycosyl compound with formula C12H15N2O11P that is a common intermediate in the biosynthesis of nikkomycins and polyoxins by bacteria.
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
C16H14N2O4S3 (394.01156840000004)
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
C17H15ClN2O5S (394.03901700000006)
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone
C18H19FN2O3S2 (394.08210760000003)
N,N-diethyl-2-[(4-fluorophenyl)methylthio]-1,3-benzoxazole-5-sulfonamide
C18H19FN2O3S2 (394.08210760000003)
2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
C17H15ClN2O3S2 (394.02125900000004)
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2,3-dideoxy-alpha-D-ribofuranos-5-yl group.
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide
C21H15ClN2O4 (394.07203000000004)
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
C22H16Cl2N2O (394.06396259999997)
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
C16H10O10S (393.99946800000004)
3-(enolpyruvyl)uridine 5-monophosphate
C12H15N2O11P (394.04134500000004)
A uridine 5-phosphate that is UMP in which the hydroxy hydrogen at position 3 has been replaced by an enolpyruvyl group.
ARN19874
C19H14N4O4S (394.07357240000005)
ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].
M1002
C15H8F6N2O2S (394.02106599999996)
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(2e,4e,7s)-8,8,8-trichloro-7-methyl-n-[(1r)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
C15H24Br2O2 (394.01429239999993)
2-(3-chloro-2,5-dihydroxyphenyl)-5-hydroxy-3,7,8-trimethoxychromen-4-one
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate
(3s,4s,6r,7r)-9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3r,4r,6s,7s)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate
methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
2-[3-chloro-2-hydroxy-4-methoxy-6-(methoxycarbonyl)benzoyl]-6-hydroxy-4-methylbenzoic acid
(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid
1-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2-methylanthracene-9,10-dione
methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
C17H14O9S (394.03585140000007)
(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione
1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate
C18H18O8S (394.07223480000005)
(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(3s,4s,6r,7r)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3s,4s,6r,7r)-7-(acetyloxy)-9-(diazyn-1-ium-1-yl)-3,13-dihydroxy-6-methyl-11-oxo-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(18),2(8),9,12,14,16-hexaen-18-olate
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(2e,4e)-8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
C18H18O8S (394.07223480000005)
3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(5r,6r)-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
C18H18O8S (394.07223480000005)
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
C15H24Br2O2 (394.01429239999993)